- Home
- AMLX vs CHY Comparison
AMLX vs CHY Comparison
Compare AMLX & CHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- CHY
- Stock Information
- Founded
- AMLX 2014
- CHY 2003
- Country
- AMLX United States
- CHY United States
- Employees
- AMLX N/A
- CHY N/A
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- CHY Investment Managers
- Sector
- AMLX Health Care
- CHY Finance
- Exchange
- AMLX Nasdaq
- CHY Nasdaq
- Market Cap
- AMLX 749.9M
- CHY 839.8M
- IPO Year
- AMLX 2022
- CHY N/A
- Fundamental
- Price
- AMLX $13.48
- CHY $11.47
- Analyst Decision
- AMLX Strong Buy
- CHY
- Analyst Count
- AMLX 7
- CHY 0
- Target Price
- AMLX $15.14
- CHY N/A
- AVG Volume (30 Days)
- AMLX 2.0M
- CHY 128.3K
- Earning Date
- AMLX 11-06-2025
- CHY 01-01-0001
- Dividend Yield
- AMLX N/A
- CHY 10.11%
- EPS Growth
- AMLX N/A
- CHY N/A
- EPS
- AMLX N/A
- CHY N/A
- Revenue
- AMLX N/A
- CHY N/A
- Revenue This Year
- AMLX N/A
- CHY N/A
- Revenue Next Year
- AMLX N/A
- CHY N/A
- P/E Ratio
- AMLX N/A
- CHY N/A
- Revenue Growth
- AMLX N/A
- CHY N/A
- 52 Week Low
- AMLX $2.60
- CHY $9.97
- 52 Week High
- AMLX $15.15
- CHY $12.16
- Technical
- Relative Strength Index (RSI)
- AMLX 61.47
- CHY 64.81
- Support Level
- AMLX $12.35
- CHY $11.26
- Resistance Level
- AMLX $13.75
- CHY $11.45
- Average True Range (ATR)
- AMLX 0.82
- CHY 0.10
- MACD
- AMLX -0.22
- CHY 0.00
- Stochastic Oscillator
- AMLX 41.86
- CHY 84.37
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
About CHY Calamos Convertible and High Income Fund
Calamos Convertible & High Income Fund is a diversified, closed-end management investment company. Its objective is to provide total return through a combination of capital appreciation and current income. The firm invests in a diversified portfolio of convertible securities and high-yield securities.